Pharma companies need extra anti-corruption vigilance during a pandemic
ADOBE
The emergence and spread of Covid-19 has heightened the risk of transnational corruption for most industries. Pharma companies are especially vulnerable.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario